SBC Medical Group
SBC
56 hedge funds and large institutions have $13.5M invested in SBC Medical Group in 2026 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 7 reducing their positions, and 4 closing their positions.
371% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 7
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
123% more capital invested
Capital invested by funds: $6.07M → $13.5M (+$7.47M)
12% more funds holding
Funds holding: 50 → 56 (+6)
2.87% more ownership
Funds ownership: 1.42% → 4.29% (+2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LK
Lumbard & Kellner
Hollis,
New Hampshire
|
+$5.8M |
| 2 |
BlackRock
New York
|
+$1.71M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$491K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$448K |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$423K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$105K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$31.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.46K |
| 4 |
EP
Essential Partners
Rancho Santa Fe,
California
|
-$1.71K |
| 5 |
GI
GAMMA Investing
Foster City,
California
|
-$1.62K |
SBC Hedge Fund Activity: Q2 2026 in Review
56 of the 8,337 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q2 2026, worth a combined $13.5M — up 123% from $6.07M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new SBC positions and 4 closed out — a net gain of 8 holders — while 33 added to existing stakes and 7 trimmed.
The largest buyer was Lumbard & Kellner, adding an estimated $5.8M. The largest seller was Goldman Sachs, exiting entirely with an estimated $105K sold.
- 56 institutional investors held SBC Medical Group (SBC) as of Q2 2026, up from 50 in Q1 2026.
- Funds reported $13.5M of SBC Medical Group stock for Q2 2026, up 123% quarter-over-quarter.
- 12 funds opened new SBC Medical Group positions in Q2 2026 and 4 closed out, a net change of +8 holders.
- The largest SBC Medical Group buyer in Q2 2026 was Lumbard & Kellner, an estimated $5.8M added.
- The largest SBC Medical Group seller in Q2 2026 was Goldman Sachs, an estimated $105K sold.
Based on aggregated 13F filings for Q2 2026.